Latest Market News

HMC Capital has secured A$1.35 billion in private credit mandates from global investors, boosting its Australian commercial real estate lending platform and setting the stage for larger loan originations.

PPK Group has cleared all conditions for selling its 39.85% stake in Craig International Ballistics, setting the stage for completion before the financial year closes.

Big River Industries expects FY26 EBITDA growth around 8% despite Q4 revenue softness and forecasts double-digit growth for FY27, while initiating a strategic options review.

Motio Limited expects FY26 Cash EBITDA to exceed prior year by more than 24%, driven by record monthly revenues and broad-based business momentum.

Comms Group has agreed to divest its onPlatinum IT managed services division for A$30 million, a move that simplifies its business and boosts balance sheet strength ahead of FY27.

Pantera Minerals has delivered standout Phase 2 exploration results at its Gillham Project in Arkansas, revealing antimony grades up to 19.2% and silver assays as high as 63.8 g/t, setting the stage for imminent maiden drilling.

Elevra Lithium has commenced construction on its North American Lithium expansion, backed by a recent capital raise that fully funds the project. The expansion aims to boost spodumene concentrate output by up to 20% and reduce operating costs by mid-2027.

SRJ Technologies' subsidiary ACE inks a strategic MOU with Australian robotics leader Nexxis, aiming to combine cutting-edge robotic platforms with advanced data analytics to enhance asset inspections in the energy sector.

Lunnon Metals has greenlit a $13 million FY2027 exploration budget to aggressively test a conceptual 1.2-2.4 million ounce gold target at its Foster-Baker area within the St Ives gold camp, aiming to drill more metres than in any year over the past six decades.

Miramar Resources has more than doubled the gold Exploration Target at its Gidji JV Project near Kalgoorlie, citing extensive new drilling data. The company is now advancing towards resource estimation and mining lease applications, eyeing deeper bedrock mineralisation potential.

Neuren’s partner Acadia secures positive CHMP opinion for DAYBU® in Rett syndrome, paving the way for first EU treatment approval and triggering significant milestone payments for Neuren.

TruScreen Group posted a NZ$2.25 million loss for FY2026, with its auditor highlighting material uncertainty over the company’s ability to continue without further funding. Revenue rose to NZ$2.4 million amid geographic expansion, but cash burn and accumulated losses remain significant.